Nanostructured lipid carriers and their current application in targeted drug delivery

References

• Agrawal Y, Petkar KC, Sawant KK. 2010. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm. 401:93–102.
   PubMed Web of Science ®Google Scholar
• Alam MI, Baboota S, Ahuja A, Ali M, Ali J, Sahni JK. 2012. Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain. J Psychiatr Res. 46:1133–1138.
   PubMed Web of Science ®Google Scholar
• Alexis F, Rhee JW, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC. 2008. New frontiers in nanotechnology for cancer treatment. Urol Oncol. 26:74–85.
   PubMed Web of Science ®Google Scholar
• Araújo J, Gonzalez E, Egea MA, Garcia ML, Souto EB. 2009. Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine. 5:394–401.
   PubMed Web of Science ®Google Scholar
• Araújo J, Nikolic S, Egea MA, Souto EB, Garcia ML. 2011. Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye. Colloids Surf BBiointerfaces. 88:150–157.
   PubMed Web of Science ®Google Scholar
• Bangham AD, Horne RW. 1964. Negative staining of phospholipids and their structural modification by surface active agents as observed in electron microscope. J Mol Biol. 8:660–668.
   PubMed Web of Science ®Google Scholar
• Bharali DJ, Khalil M, Gurbuz M, Simone TM, Mousa SA. 2009. Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. Int J Nanomed. 4:1–7.
   PubMed Web of Science ®Google Scholar
• Chen CC, Tsai TH, Huang ZR, Fang JY. 2010. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm. 74:474–482.
   PubMed Web of Science ®Google Scholar
• Chen-yu G, Chun-fena Y, Qi-luc L, Qi T, Yan-wei X, Wei-na L, Guang-xi Z. 2012. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int J Pharm. 430:292–298.
   PubMed Web of Science ®Google Scholar
• Cirri M, Bragagni M, Mennini N, Mura P. 2012. Development of a new delivery system consisting in ‘‘drug – in cyclodextrin – in nanostructured lipid carriers’’ for ketoprofen topical delivery. Eur J Pharm Biopharm. 80:46–53.
   PubMed Web of Science ®Google Scholar
• Das S, Chaudhary A. 2011. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech. 12:62–76.
   PubMed Web of Science ®Google Scholar
• Date AA, Joshi MD, Patravale VB. 2007. Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev. 59:505–521.
   PubMed Web of Science ®Google Scholar
• Doktorovová S, Araújo J, Garcia ML, Rakovský E, Souto EB. 2010. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC). Colloids Surf BBiointerfaces. 75:538–542.
   PubMed Web of Science ®Google Scholar
• Domb AJ. 1995. Long acting injectable oxytetracycline-liposphere formulations. Int J Pharm. 124:271–278.
   Web of Science ®Google Scholar
• Domingo C, Saurina J. 2012. An overview of the analytical characterization of nanostructured drug delivery systems: towards green and sustainable pharmaceuticals: a review. Anal Chim Acta. 744:8–22.
   PubMed Web of Science ®Google Scholar
• Eldem T, Speiser P, Hincal A. 1991. Optimization of spray-dried and congelated lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm Res. 8:47–54
   PubMed Web of Science ®Google Scholar
• Esposito E, Mariani P, Ravani L, Contado C, Volta M, Bido S, et al. 2012. Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study. Eur J Pharm Biopharm. 80:306–314.
   PubMed Web of Science ®Google Scholar
• Fang JY, Fang CL, Liu CH, Su YH. 2008. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm. 70:633–640.
   PubMed Web of Science ®Google Scholar
• Fathi M, Varshosaz J, Mohebbi M, Shahidi F. 2013. Hesperetin-loaded solid lipid nanoparticles and nanostructure lipid carriers for food fortification: preparation, characterization, and modeling. Food Bioprocess Tech. 6:1464–1475.
   Web of Science ®Google Scholar
• Freitas C, Müller RH. 1999a. Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. Eur J Pharm Biopharm. 47:125–132.
   PubMed Web of Science ®Google Scholar
• Freitas C, Müller RH. 1999b. Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte. J Microencapsul. 16:59–71.
   PubMed Web of Science ®Google Scholar
• García L, Urbiola K, Düzgüneş N, Tros de Ilarduya C. 2012. Lipopolyplexes as nanomedicines for therapeutic gene delivery. Methods Enzymol. 509:327–338.
   PubMed Web of Science ®Google Scholar
• Gasco MR. 1993. Method for producing solid lipid microspheres having a narrow size distribution. US Pat. No. 5250236.
   Google Scholar
• Gohla SH, Dingler A. 2001. Scaling up feasibility of the production of solid lipid nanoparticles (SLN). Pharmazie. 56:61–63.
   PubMed Web of Science ®Google Scholar
• Gokce EH, Korkmaz E, Dellera E, Sandri G, Bonferoni MC, Ozer O. 2012. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int J Nanomed. 7:1841–1850.
   PubMed Web of Science ®Google Scholar
• Gupta M, Vyas SP. 2012. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids. 165:454–461.
   PubMed Web of Science ®Google Scholar
• Han F, Yin R, Che X, Yuan J, Cui Y, Yin H, Li S. 2012. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: Design, characterization and in vivo evaluation. Int J Pharm. 439:349–357.
   PubMed Web of Science ®Google Scholar
• Hu FQ, Yuan H, Zhang HH, Fang M. 2002. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm. 239:121–128.
   PubMed Web of Science ®Google Scholar
• Jia L, Zhang D, Li Z, Duan C, Wang Y, Feng F, et al. 2010. Nanostructured lipid carriers for parenteral delivery of silybin: biodistribution and pharmacokinetic studies. Colloids Surf BBiointerfaces. 80: 213–218.
   PubMed Web of Science ®Google Scholar
• Joshi M, Pathak S, Sharma S, Patravale V. 2008. Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: nanoject. Int J Pharm. 364:119–126.
   PubMed Web of Science ®Google Scholar
• Joshi M, Patravale V. 2008. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm. 346:124–132.
   PubMed Web of Science ®Google Scholar
• Joshi MD, Müller RH. 2009. Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm. 7:161–172.
   Google Scholar
• Kakkar V, Singh S, Singla D, Kaur IP. 2011. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res. 55:495–503.
   PubMed Web of Science ®Google Scholar
• Kovacevic A, Savic S, Vuleta G, Müller RH, Keck CM. 2011. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Int J Pharm. 406:163–172.
   PubMed Web of Science ®Google Scholar
• Lacatusu I, Badea N, Ovidiu O, Bojin D, Megha A. 2012. Highly antioxidant carotene-lipid nanocarriers: synthesis and antibacterial activity. J Nanopart Res. 14:902.
   Web of Science ®Google Scholar
• Li F, Weng Y, Wang L, He H, Yang J, Tang X. 2010. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers. Int J Pharm. 393:203–211.
   PubMed Web of Science ®Google Scholar
• Li X, Nie SF, Kong J, Li N, Ju CY, Pan WS. 2008. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm. 363:177–182.
   PubMed Web of Science ®Google Scholar
• Lin YK, Huang ZR, Zhuo RZ, Fang JY. 2010. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomed. 5:117–128.
   PubMed Web of Science ®Google Scholar
• Liu CH, Wu CT. 2010. Optimization of nanostructured lipid carriers for lutein delivery. Colloids Surf APhysicochem Eng Aspects. 353: 149–156.
   Web of Science ®Google Scholar
• Liu D, Liu Z, Wang L, Zhang C, Zhang N. 2011. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B Biointerfaces. 85:262–269.
   PubMed Web of Science ®Google Scholar
• Liu GY, Wang JM, Xia Q. 2012. Application of nanostructured lipid carrier in food for the improved bioavailability. Eur Food Res Technol. 234:391–398.
   Web of Science ®Google Scholar
• Lombardi Borgia S, Regehly M, Sivaramakrishnan R, Mehnert W, Korting HC, Danker K, et al. 2005. Lipid nanoparticles for skin penetration enhancement—correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release. 110:151–163.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. 2001. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 47:165–196.
   PubMed Web of Science ®Google Scholar
• Mishra B, Patel BB, Tiwari S. 2010. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine. 6:9–24.
   PubMed Web of Science ®Google Scholar
• Moulik SP, Paul BK. 1998. Structure, dynamics and transport properties of microemulsions. Adv Colloid Interface Sci. 78:99–195.
   Web of Science ®Google Scholar
• Müller RH, Maassen S, Weyhers H, Mehnert W. 1996. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J Drug Target. 4:161–170.
   PubMed Web of Science ®Google Scholar
• Müller RH, Mader K, Gohla S. 2009. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 366:170–184.
   PubMedGoogle Scholar
• Müller RH, Radtke M, Wissing SA. 2002. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 54:131–155.
   PubMed Web of Science ®Google Scholar
• Nam SH, Ji XY, Park JS. 2011. Investigation of tacrolimus loaded nanostructured lipid carriers for topical drug delivery. Bull Korean Chem. 32:956–960.
   Web of Science ®Google Scholar
• Nayak AP, Tiyaboonchai W, Patankar S, Madhusudhan B, Souto EB. 2010. Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. Colloids Surf B Biointerfaces. 81: 263–273.
   PubMed Web of Science ®Google Scholar
• Pardeike J, Müller RH. 2007. Coenzyme Q10 loaded NLCs: preparation, occlusion properties and penetration enhancement. Pharm Technol Eur. 19:46–49.
   Google Scholar
• Pardeike J, Weber S, Haber T, Wagner J, Zarfl HP, Plank H, Zimmer A. 2011. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Int J Pharm. 419:329–338.
   PubMed Web of Science ®Google Scholar
• Patel RP, Singhal GB, Prajapati BG, Patel NA. 2011. Solid lipid nanoparticles and nano lipid carriers: As novel solid lipid based drug carrier. Int Res J Pharm. 2:40–52.
   Google Scholar
• Pathak P, Nagarsenker M. 2009. Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery. AAPS PharmSciTech. 10:985–992.
   PubMed Web of Science ®Google Scholar
• Patlolla RR, Chougule M, Patel AR, Jackson T, Tata PN, Singh M. 2010. Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers. J Control Release. 144:233–241.
   PubMed Web of Science ®Google Scholar
• Petersen RD, Hommoss A, Peter M, Muller RH. 2006. Nanostructured lipid carrier—a delivery system with protective functions. SOFW J. 132:64–69.
   Google Scholar
• Puglia C, Blasi P, Rizza L, Schoubben A, Bonina F, Rossi C, Ricci M. 2008. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int J Pharm. 357:295–304.
   PubMed Web of Science ®Google Scholar
• Radtke M, Müller RH. 2001. Nanostructured lipid carriers: the new generation of lipid drug carriers. New Drugs. 2:48–52.
   Google Scholar
• Reithmeier H, Hermann J, Göpferich A. 2001. Lipid microparticles as a parenteral controlled release device for peptides. J Control Release. 73:339–350.
   PubMed Web of Science ®Google Scholar
• Salunkhe SS, Bhatia NM, Pokharkar VB, Throat JD, Bhatia MS. 2013. Topical delivery of Idebenone using nanostructured lipid carriers: evaluations of sun-protection and anti-oxidant effects. J Pharm Investigation. 43:287–303.
   Google Scholar
• Sanad RA, Abdelmalak NS, Elbayoomy TS, Badawi AA. 2010. Formulation of novel oxybenzone-loaded nanostructured lipid carriers (NLCs). AAPS PharmSciTech. 11:1684–94.
   PubMed Web of Science ®Google Scholar
• Schäfer-Korting M, Mehnert W, Korting HC. 2007. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 59:427–443.
   PubMed Web of Science ®Google Scholar
• Schubert MA, Müller-Goymann CC. 2003. Solvent injection as a new approach for manufacturing lipid nanoparticles—evaluation of the method and process parameters. Eur J Pharm Biopharm. 55:125–131.
   PubMed Web of Science ®Google Scholar
• Schwarz C, Mehnert W, Lucks JS, Müller RH. 1994. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Release. 30:83–96.
   Web of Science ®Google Scholar
• Shahgaldian P, Da Silva E, Coleman AW, Rather B, Zaworotko MJ. 2003. Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters. Int J Pharm. 253:23–38.
   PubMed Web of Science ®Google Scholar
• Shen J, Deng Y, Jin X, Ping Q, Su Z, Li L. 2010. Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: improving in vivo ocular distribution. Int J Pharm. 402:248–253.
   PubMed Web of Science ®Google Scholar
• Souto EB, Müller RH. 2005. SLN and NLC for topical delivery of ketoconazole. J Microencapsul. 22:501–510.
   PubMed Web of Science ®Google Scholar
• Souza LG, Silva EJ, Martins ALL, Mota MF, Braga RC, Lima EM, et al. 2011. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. Eur J Pharm Biopharm. 79:189–196.
   PubMed Web of Science ®Google Scholar
• Tan SW, Billa N, Roberts CR, Burley JC. 2010. Surfactant effects on the physical characteristics of Amphotericin B-containing nanostructured lipid carriers. Colloids Surf A Physicochem Eng Aspects. 372:73–79.
   Web of Science ®Google Scholar
• Taratula O, Kuzmov A, Shah M, Garbuzenko OB, Minko T. 2013. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. J Control Release. 171:349–357.
   PubMed Web of Science ®Google Scholar
• Tiwari R, Pathak K. 2011. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm. 415:232–243.
   PubMed Web of Science ®Google Scholar
• Trotta M, Debernardi F, Caputo O. 2003. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm. 257:153–160.
   PubMed Web of Science ®Google Scholar
• Melike U, Gulgun Y. 2007. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedecine. 2:289–300.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Hassanzadeh F, Sadeghi H, Andalib S. 2012. Synthesis of octadecylamine-retinoic acid conjugate for enhanced cytotoxic effects of 5-FU using LDL targeted nanostructured lipid carriers. Euro J Med Chem. 54:429–438.
   PubMed Web of Science ®Google Scholar
• Westesen K, Bunjes H, Koch MHJ. 1997. Physicochemical characterisation of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release. 48:223–236.
   Web of Science ®Google Scholar
• Wretlind A. 1981. Development of fat emulsions. JPEN J Parenter Enteral Nutr. 5:230–235.
   PubMed Web of Science ®Google Scholar
• Yang XY, Li YX, Li M, Zhang L, Feng LX, Zhang N. 2013. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Cancer Lett. 334:338–345.
   PubMed Web of Science ®Google Scholar
• Zhang T, Chen J, Zhang Y, Shen Q, Pan W. 2011. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. Eur J Pharm Sci. 43:174–179.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu J, Qiao H, Liu H, Ni J, Zhang W, Shi Y. 2010. Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology. Powder Technol. 197:120–128.
   Web of Science ®Google Scholar
• Zhang Z, Sha X, Shen A, Wang Y, Sun Z, Gu Z, Fang X. 2008. Polycation nanostructured lipid carrier, a novel nonviral vector constructed with triolein for efficient gene delivery. Biochem Biophys Res Commun. 370:478–48.
   PubMed Web of Science ®Google Scholar
• Zhao C, Liu Y, Fan T, Zhou D, Yang Y, Jin Y, Zhang Z, Huang Y. 2012. A novel strategy for encapsulating poorly soluble drug into nanostructured lipid carriers for intravenous administration. Pharm Dev Technol. 17:443–456.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Feng C, Liao W, Zhang Y, Tang S. 2013. Target delivery of MYCN siRNA by folate-nanoliposomes delivery system in a metastatic neuroblastoma model. Cancer Cell Int. 13:65–70.
   PubMed Web of Science ®Google Scholar
• Zhuang CY, Li N, Wang M, Zhang XN, Pan WS, Peng JJ, et al. 2010. Preparation and characterization of Vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm. 394:179–185.
   PubMed Web of Science ®Google Scholar
• zur Mühlen A, Schwarz C, Mehnert W. 1998. Solid lipid nanoparticles (SLN) for controlled drug delivery–drug release and release mechanism. Eur J Pharm Biopharm. 45:149–155.
   PubMed Web of Science ®Google Scholar